JPMorgan Chase & Co’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
210,125
+57,909
| +38% | +$617K | ﹤0.01% | 3260 |
|
|
2025
Q1 | $1.72M | Buy |
+152,216
| New | +$1.72M | ﹤0.01% | 3356 |
|
|
2024
Q4 | – | Sell |
-4
| Closed | -$42 | – | 6569 |
|
|
2024
Q3 | $42 | Hold |
4
| – | – | ﹤0.01% | 6078 |
|
|
2024
Q2 | $41 | Hold |
4
| – | – | ﹤0.01% | 6035 |
|
|
2024
Q1 | $41 | Buy |
+4
| New | +$41 | ﹤0.01% | 6062 |
|